General Medicine raises $120 million to expand healthcare store

General Medicine, a San Francisco-based company, has secured $120 million in Series B financing to expand its healthcare store nationwide. The funding round was led by Andreessen Horowitz, with additional investments from Matrix, VXI Capital, Eli Lilly and Company, Mercy Health through Granger Management, and BoxGroup. The company boasts a catalog of over 2,900 products and services, ranging from medications and labs to telehealth and specialist e-consults, and select in-person visits and procedures.

Since its nationwide launch in May 2025, General Medicine has onboarded hundreds of thousands of customers. The company's services have helped improve healthcare access, with an average Net Promoter Score of 80 and 83% of customers reporting that the company assisted them in addressing a health issue they had delayed for over six months.

The additional funding will be allocated towards broadening the company's offerings to include additional care categories. Customers can now purchase care directly when needed, consult with a licensed clinician available the same day, or utilize the company's AI chat to explore symptoms and understand treatment options. A licensed clinician determines clinical appropriateness when required.